Diltiazem Hydrochloride NDC 70436-193

NDC codes

FDA NDC Directory

Product NDC (as listed)70436-193Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70436-0193Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70436-193-01	70436019301	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-193-01)Marketed from Sep 5, 2022
70436-193-02	70436019302	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-193-02)Marketed from Sep 5, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Diltiazem Hydrochloride
Generic name (nonproprietary): diltiazem hydrochloride
Active ingredients: Diltiazem hydrochloride — 240 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Slate Run Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216304
Marketing start: Sep 5, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)
Identifiers: Product ID 70436-193_584a0d75-656b-7918-e063-6294a90a278eSPL ID 584a0d75-656b-7918-e063-6294a90a278eSPL set ID e66665e8-22eb-f5cd-e053-2a95a90a72e4RxCUI 830837, 830845, 830861UNII OLH94387TEUPC 0370436192014, 0370436193028, 0370436192021, 0370436193011, 0370436191017
Pharmacologic class: Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470436019301 followed by a unit qualifier and the quantity

Package 70436-0193-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 5, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Diltiazem Hydrochloride Extended-Release Capsules are indicated for the treatment of hypertension. Diltiazem hydrochloride may be used alone or in combination with other antihypertensive medications, such as diuretics. Diltiazem Hydrochloride Extended-Release Capsules are indicated for the management of chronic stable angina.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216304

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216304
Product	Strength	Form · route	Labeler	Product NDC
Diltiazem Hydrochloride	Diltiazem hydrochloride 120 mg/1	Capsule, Extended releaseOral	Slate Run Pharmaceuticals, LLC	70436-191
Diltiazem Hydrochloride	Diltiazem hydrochloride 180 mg/1	Capsule, Extended releaseOral	Slate Run Pharmaceuticals, LLC	70436-192